Fusion Antibodies PLC Net Asset Quality Index
Fusion Antibodies PLC net asset quality index. Fusion Antibodies PLC (FAB) has a Net Asset Quality Index of 40.1% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of GBX1.81 Million minus total liabilities of GBX1.09 Million yields net assets of GBX726.00K. A higher index indicates a stronger, lower-leverage balance sheet. See Fusion Antibodies PLC (FAB) net assets for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Fusion Antibodies PLC (2006–2025)
Net asset quality index of Fusion Antibodies PLC from 2006 to 2025. This chart shows how Fusion Antibodies PLC's Net Asset Quality Index has evolved across 20 annual periods from 2006 to 2025. As of September 2025, the index stands at 40.1%, representing net assets of GBX726.00K against total assets of GBX1.81 Million GBX. Check FAB strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Fusion Antibodies PLC Net Asset Quality Index by Year (2006–2025)
Fusion Antibodies PLC net asset quality index by year from 2006 to 2025. The table below presents the year-by-year Net Asset Quality Index for Fusion Antibodies PLC from 2006 to 2025, covering 20 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see how much is Fusion Antibodies PLC worth.
| Year | Quality Index | Net Assets (GBX) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 50.6% | GBX669.00K | GBX1.32 Million | GBX654.00K | ▼ -23.5 pp |
| 2024 | 74.1% | GBX1.79 Million | GBX2.42 Million | GBX627.00K | ▲ +19.6 pp |
| 2023 | 54.5% | GBX1.12 Million | GBX2.06 Million | GBX939.00K | ▼ -20.5 pp |
| 2022 | 75.0% | GBX3.68 Million | GBX4.92 Million | GBX1.23 Million | ▼ -6.5 pp |
| 2021 | 81.4% | GBX4.75 Million | GBX5.83 Million | GBX1.08 Million | ▲ +1.8 pp |
| 2020 | 79.7% | GBX4.81 Million | GBX6.04 Million | GBX1.23 Million | ▼ -6.1 pp |
| 2019 | 85.8% | GBX5.35 Million | GBX6.24 Million | GBX888.53K | ▼ -5.4 pp |
| 2018 | 91.2% | GBX6.58 Million | GBX7.21 Million | GBX633.59K | ▲ +12.1 pp |
| 2017 | 79.1% | GBX1.71 Million | GBX2.16 Million | GBX450.22K | ▲ +1.1 pp |
| 2016 | 78.0% | GBX1.46 Million | GBX1.87 Million | GBX411.43K | ▲ +32.3 pp |
| 2015 | 45.6% | GBX169.29K | GBX370.96K | GBX201.67K | ▲ +40.4 pp |
| 2014 | 5.2% | GBX16.32K | GBX313.89K | GBX297.57K | ▼ -11.3 pp |
| 2013 | 16.5% | GBX50.13K | GBX303.69K | GBX253.56K | ▲ +36.2 pp |
| 2012 | -19.7% | GBX-73.00K | GBX370.00K | GBX443.00K | ▼ -65.5 pp |
| 2011 | 45.8% | GBX323.00K | GBX705.00K | GBX382.00K | ▼ -16.9 pp |
| 2010 | 62.8% | GBX514.00K | GBX819.00K | GBX305.00K | ▲ +39.9 pp |
| 2009 | 22.9% | GBX188.00K | GBX821.00K | GBX633.00K | ▼ -35.7 pp |
| 2008 | 58.6% | GBX655.00K | GBX1.12 Million | GBX462.00K | ▲ +1.0 pp |
| 2007 | 57.6% | GBX608.00K | GBX1.05 Million | GBX447.00K | ▲ +16.3 pp |
| 2006 | 41.3% | GBX204.00K | GBX494.00K | GBX290.00K | — |